A pathogenic isolate of rhesus cytomegalovirus (rhCMV 180.92) was cloned, sequenced, and annotated. Comparisons with the published rhCMV 68.1 genome revealed 8 open reading frames (ORFs) in isolate 180.92 that are absent in 68.1, 10 ORFs in 68.1 that are absent in 180.92, and 34 additional ORFs that were not previously annotated. Most of the differences appear to be due to genetic rearrangements in both isolates from a region that is frequently altered in human CMV (hCMV) during in vitro passage. These results indicate that the rhCMV ORF repertoire is larger than previously recognized. Like hCMV, understanding of the complete coding capacity of rhCMV is complicated by genomic instability and may require comparisons with additional isolates in vitro and in vivo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1440457 | PMC |
| http://dx.doi.org/10.1128/JVI.80.8.4179-4182.2006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unlabelled: Cytomegaloviruses are highly species-specific as they replicate only in cells of their own or a closely related species. For instance, human cytomegalovirus cannot replicate in rodent cells, and mouse cytomegalovirus (MCMV) cannot replicate in human and monkey cells. However, the mechanisms underlying the host species restriction remain poorly understood.
View Article and Find Full Text PDFFunctional genomic analysis of the 68-1 RhCMV- vaccine reveals an IL-15 response signature that is conserved with vector attenuation.
Front Immunol
October 2024
Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, WA, United States.
Article Synopsis
- - Tuberculosis (TB) remains a significant global health threat, and researchers are exploring innovative vaccine strategies using modified cytomegalovirus (CMV) vectors to enhance immune memory against TB.
- - The study examined two variations of the RhCMV/TB vaccine in rhesus macaques, revealing that they stimulate robust immune responses, characterized by specific genetic signatures linked to protection against related viral infections.
- - Findings highlighted that while both vaccine types initiated an immune response, the modified version lacking the pp71 protein did not sustain protective gene expression as effectively, suggesting that pp71 is crucial for long-term vaccine efficacy against TB.
Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8 T cells.
Sci Immunol
October 2024
Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
Article Synopsis
- Rhesus cytomegalovirus (RhCMV) vectors help control simian immunodeficiency virus (SIV) by activating CD8 T cells that are restricted by major histocompatibility complex (MHC)-E.
- The effectiveness of these responses relies on the deletion of eight specific RhCMV gene sequences that are also found in human cytomegalovirus (HCMV).
- HCMV's UL18 gene inhibits unconventional T cell activation by binding to an receptor (LIR-1), so removing this binding ability from the HCMV genes in vaccines could enhance the induction of protective MHC-E-restricted T cells.
Pre-challenge gut microbial signature predicts RhCMV/SIV vaccine efficacy in rhesus macaques.
Microbiol Spectr
November 2024
Department of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
Article Synopsis
- Rhesus macaques vaccinated with RhCMV/SIV show about 59% protection against SIVmac239M exposure, but the mechanism behind this protection is still unclear.
- Researchers explored how the gut microbiome of the macaques influences the effectiveness of the vaccine, analyzing rectal swabs for microbial profiles before and after SIV exposure.
- They discovered a common gut microbial signature associated with vaccine protection across different vaccination groups, indicating that gut microbiota play a significant role in the immune response to the RhCMV/SIV vaccine.
Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins.
J Virol
September 2024
Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Unlabelled: The signal sequences of the human cytomegalovirus (CMV) UL40 protein and its rhesus CMV (RhCMV) counterpart, Rh67, contain a peptide (VMAPRT[L/V][F/I/L/V]L, VL9) that is presented by major histocompatibility complex (MHC) antigen E (MHC-E). The CMV VL9 peptides replace VL9 peptides derived from classical MHC (Ia) signal sequences, which are lost when CMV disrupts antigen processing and presentation and MHC Ia expression. This allows infected cells to maintain MHC-E surface expression and escape killing by Natural Killer cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!